
open access
메뉴
E-ISSN : 2671-6771
Congenital hypothyroidism (CH) is one of the most common endocrine disorders in newborns and an important preventable cause of intellectual disability. Thyroid dyshormonogenesis accounts for approximately 15%–20% of CH cases and results from defects in thyroid hormone synthesis. Recent advances in molecular genetics have identified several key genes involved in this process, including SLC5A5, TPO, DUOX2, DUOXA2, TG, SLC26A4, and IYD. These genes affect different steps of hormone production, such as iodide transport, organification, thyroglobulin synthesis, and iodide recycling. Clinical presentations vary widely, ranging from transient to permanent hypothyroidism, depending on the type and severity of genetic defects. A precise genetic diagnosis has important clinical implications. It can guide individualized treatment strategies and help predict disease courses, including the likelihood of transient versus permanent hypothyroidism. In addition, early identification of affected family members enables timely intervention and prevention of developmental complications. In conclusion, thyroid dyshormonogenesis represents a genetically heterogeneous group of disorders. Integrating genetic, biochemical, and clinical data is essential for precision management and may improve long-term outcomes in patients with congenital hypothyroidism.